
Jennifer Temel
Director of the Supportive Oncology Unit for Research, Care, and Education (SOURCE), Massachusetts General Hospital · UCLA David Geffen School of Medicine/UCLA Medical Center
Credentials: · · ·
History
Present

- 2000–2002

Research
Early palliative care for patients with metastatic non-small-cell lung cancer
New England Journal of Medicine · 2010 · First of 12 authors · Corresponding · 5,483 citations
Genotypic and histological evolution of lung cancers acquiring resistance to EGFR inhibitors
Science Translational Medicine · 2011 · 2,891 citations
Systematic review or meta-analysis · Journal of Clinical Oncology · 2017 · 1,578 citations

129 papers · 10 as a resident

81 papers

76 papers

52 papers · 35 as a resident

47 papers

35 papers · 9 as a fellow

23 papers

21 papers
Grants
- 2026–2031
National Cancer Institute · R01
Contact PI · $604.3K · Massachusetts General Hospital
- 2025–2030
National Cancer Institute · R01
Contact PI · $1.7M · Massachusetts General Hospital
- 2014–2030
Workshop on Research Methods in Supportive Oncology
National Cancer Institute · R25
Contact PI · $2.7M · Dana-Farber Cancer Inst
- 2018–2023
National Cancer Institute · R01
Contact PI · $2.4M · Massachusetts General Hospital
Clinical trials
- 2022–2029
Specialty Compared to Oncology Delivered Palliative Care for Patients With Acute Myeloid Leukemia
Principal investigator · Recruiting
Massachusetts General Hospital
- 2021
Care Transition Intervention for Patients With Cancer
Principal investigator · Completed
Massachusetts General Hospital
- 2018–2024
Early Integrated Telehealth Versus In-Person Palliative Care for Patients With Lung Cancer
Principal investigator · Completed
Massachusetts General Hospital
- 2018–2023
Principal investigator · Completed
Massachusetts General Hospital


